SIX •
Healthcare •
Biotechnology •
Quote as of 08/18/2026 14:24
Company Profile
IndustryBiotechnology
SectorHealthcare
ExchangeSIX
Market Capitalization36.09 mln
Float37.20 mln
Relative Strength
93
/ 100
Top performer
Debt / Equity
0.05
Debt-free
ROE
-51.56
Deeply negative
Dividend Yield
0.00%
No dividend
DPS
0.00
No dividend
Payout Ratio
0%
No payout
Business Description
Founded in 2025 and headquartered in Lausanne, Switzerland, MindMaze Therapeutics builds technology designed to help patients with neurological conditions. The company combines brain science with digital treatment tools to tackle serious and widespread health problems in the field of neurology.
